Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2010 • 14,016 citations

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

2015 • 7,407 citations

Pembrolizumab versus Ipilimumab in Advanced Melanoma

2015 • 5,239 citations

Nivolumab in Previously Untreated Melanoma withoutBRAFMutation

2014 • 4,953 citations

Myasthenia Gravis

1997 • 2,469 citations

Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

2012 • 1,353 citations

Antibody to acetylcholine receptor in myasthenia gravis

1998 • 1,149 citations

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

2001 • 1,134 citations

Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value

1976 • 1,123 citations

Myasthenia Gravis

1994 • 1,090 citations

Prevalence and Relative Risk of Other Autoimmune Diseases in Subjects with Autoimmune Thyroid Disease

2010 • 428 citations

Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma

2014 • 107 citations

Anti-PD1 Following Ipilimumab for Mucosal Melanoma: Durable Tumor Response Associated with Severe Hypothyroidism and Rhabdomyolysis

2013 • 100 citations

Anti-CTLA-4 Antibody Treatment Triggers Determinant Spreading and Enhances Murine Myasthenia Gravis

2001 • 72 citations

Programmed Death-1: From gene to protein in autoimmune human myasthenia gravis

2007 • 25 citations

Anti-acetylcholine receptor antibody in aged individuals and in patients with down's syndrome

1983 • 15 citations